Wellspring is focused on the discovery and development of small molecule drugs that target signal transduction networks for the treatment of cancer and other diseases. Through partnerships with academic and industry experts, we are translating chemical and biological insights into novel, highly targeted drugs. Our team has a proven track record, having previously played important roles in the discovery and development of clinical-stage compounds for the treatment of cancer and immune-mediated inflammatory disease at Intellikine.